|
ZFYVE26 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.60647100861434E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.86359999996022E-06 |
| Normal-vs-Stage2 |
3.179500E-04 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
4.540400E-03 |
| Stage1-vs-Stage2 |
5.292000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
9.706200E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
5.892800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.2394997795393E-10 |
| Normal-vs-AfricanAmerican |
1.457390E-01 |
| Normal-vs-Asian |
5.123600E-02 |
| Caucasian-vs-AfricanAmerican |
2.689900E-02 |
| Caucasian-vs-Asian |
7.798400E-02 |
| AfricanAmerican-vs-Asian |
5.953200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.54420000000522E-05 |
| Normal-vs-Female |
1.38430000018452E-07 |
| Male-vs-Female |
4.860600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.656800E-03 |
| Normal-vs-Extreme_Weight |
6.33770000035838E-07 |
| Normal-vs-Obese |
1.044370E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
8.606600E-01 |
| Normal_Weight-vs-Obese |
1.960390E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
4.538200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.93910004614639E-09 |
| Normal-vs-Age(41-60Yrs) |
1.255210E-03 |
| Normal-vs-Age(61-80Yrs) |
1.23730000023414E-07 |
| Normal-vs-Age(81-100Yrs) |
2.145000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.295400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.825380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.414200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.570800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.598400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.285200E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
7.830800E-01 |
| Normal-vs-Grade 3 |
5.260200E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
4.321600E-01 |
| Grade 2-vs-Grade 4 |
7.830800E-01 |
| Grade 3-vs-Grade 4 |
5.260200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.75489999596235E-08 |
| Normal-vs-N1 |
5.720400E-03 |
| N0-vs-N1 |
5.468600E-01 |
|
|
